Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

VCG Tjan-Heijnen; IEG van Hellemond; PGM Peer; ACP Swinkels; CH Smorenburg; MJC van der Sangen; JR Kroep; H de Graaf; AH Honkoop; FLG Erdkamp; F van den Berkmortel; Meta Boer; WK de Roos; SC Linn; A L T Imholz; Caroline Seynaeve

doi:10.1016/s1470-2045(17)30600-9

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

VCG Tjan-Heijnen, IEG van Hellemond, PGM Peer, ACP Swinkels, CH Smorenburg, MJC van der Sangen, JR Kroep, H de Graaf, AH Honkoop, FLG Erdkamp, F van den Berkmortel, Meta Boer, WK de Roos, SC Linn, A L T Imholz, Caroline Seynaeve

Research output: Contribution to journal › Article › Academic › peer-review

119 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1502-1511
Number of pages	10
Journal	Lancet Oncology
Volume	18
Issue number	11
DOIs	https://doi.org/10.1016/s1470-2045(17)30600-9
Publication status	Published - 2017

Research programs

EMC MM-03-86-01

Access to Document

10.1016/s1470-2045(17)30600-9

http://hdl.handle.net/1765/102417

Cite this

Tjan-Heijnen, VCG., van Hellemond, IEG., Peer, PGM., Swinkels, ACP., Smorenburg, CH., van der Sangen, MJC., Kroep, JR., de Graaf, H., Honkoop, AH., Erdkamp, FLG., van den Berkmortel, F., Boer, M., de Roos, WK., Linn, SC., Imholz, A. L. T., & Seynaeve, C. (2017). Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial. Lancet Oncology, 18(11), 1502-1511. https://doi.org/10.1016/s1470-2045(17)30600-9

@article{80d98496755040928ab48af43c4b3bf1,

title = "Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial",

author = "VCG Tjan-Heijnen and {van Hellemond}, IEG and PGM Peer and ACP Swinkels and CH Smorenburg and {van der Sangen}, MJC and JR Kroep and {de Graaf}, H and AH Honkoop and FLG Erdkamp and {van den Berkmortel}, F and Meta Boer and {de Roos}, WK and SC Linn and Imholz, {A L T} and Caroline Seynaeve",

year = "2017",

doi = "10.1016/s1470-2045(17)30600-9",

language = "Undefined/Unknown",

volume = "18",

pages = "1502--1511",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "11",

}

Tjan-Heijnen, VCG, van Hellemond, IEG, Peer, PGM, Swinkels, ACP, Smorenburg, CH, van der Sangen, MJC, Kroep, JR, de Graaf, H, Honkoop, AH, Erdkamp, FLG, van den Berkmortel, F, Boer, M, de Roos, WK, Linn, SC, Imholz, ALT & Seynaeve, C 2017, 'Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial', Lancet Oncology, vol. 18, no. 11, pp. 1502-1511. https://doi.org/10.1016/s1470-2045(17)30600-9

TY - JOUR

T1 - Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

AU - Tjan-Heijnen, VCG

AU - van Hellemond, IEG

AU - Peer, PGM

AU - Swinkels, ACP

AU - Smorenburg, CH

AU - van der Sangen, MJC

AU - Kroep, JR

AU - de Graaf, H

AU - Honkoop, AH

AU - Erdkamp, FLG

AU - van den Berkmortel, F

AU - Boer, Meta

AU - de Roos, WK

AU - Linn, SC

AU - Imholz, A L T

AU - Seynaeve, Caroline

PY - 2017

Y1 - 2017

U2 - 10.1016/s1470-2045(17)30600-9

DO - 10.1016/s1470-2045(17)30600-9

M3 - Article

SN - 1470-2045

VL - 18

SP - 1502

EP - 1511

JO - Lancet Oncology

JF - Lancet Oncology

IS - 11

ER -